Polymorphic compounds and uses thereof
US12295962B2 · kind B2 · utility
0Cited by
20References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2024 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Apr 2, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides co-crystal and salt forms, and compositions and methods thereof, useful for treating various diseases, disorders or conditions in which EP4 prostaglandin receptors are implicated in the mediation of a proliferative disorder, by the administration of small molecule therapeutics acting as inhibitors of prostaglandin EP4 receptor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.